Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans.
about
Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)The pharmacology and toxicology of "ecstasy" (MDMA) and related drugsExecutive dysfunction in substance dependent individuals during drug use and abstinence: An examination of the behavioral, cognitive and emotional correlates of addictionCortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of bioenergetic stress in ecstasy users.Ecstasy: are animal data consistent between species and can they translate to humans?A comprehensive review of MDMA and GHB: two common club drugs.Decision-making in chronic ecstasy users: a systematic review.Quitting ecstasy: an investigation of why people stop taking the drug and their subsequent mental health.The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans.3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.Preventing problems in Ecstasy users: reduce use to reduce harm.Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.Inhibition of MDMA-induced increase in cortisol does not prevent acute impairment of verbal memoryTolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges.Serotonergic vulnerability and depression: assumptions, experimental evidence and implications.Reward-related decision-making deficits and elevated impulsivity among MDMA and other drug users.Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms?Relationship between ecstasy use and depression: a study controlling for poly-drug use.Tri-city study of Ecstasy use problems: a latent class analysis.Neuropsychological function in ecstasy users: a study controlling for polydrug use.Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related ConditionsSleep apnea in young abstinent recreational MDMA ("ecstasy") consumers.MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used 'Ecstasy' during pregnancy.A psycho-economic model of ecstasy consumption and related consequences: a multi-site study with community samples.Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study.Altered prolactin response to M-chlorophenylpiperazine in monkeys previously treated with 3,4-methylenedioxymethamphetamine (MDMA) or fenfluramine.Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor.Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms.Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.The BDI of the beholder.Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users.Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.Ecstasy use in South Africa: findings from the South African Community Epidemiology Network on Drug Use (SACENDU) project (January 1997-December 2001).Are ecstasy users biased toward endorsing somatic mental health symptoms? Results from a general community sample.Long-term effects of MDMA (Ecstasy) on the human central nervous system revealed by visual evoked potentials.Electrophysiological indices of response inhibition in human polydrug users.Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users.The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users.Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits.Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use.
P2860
Q24619949-1F7F8256-4B8F-41CC-B1A1-799D076DE5B7Q28361466-8595D30B-88C0-4DCA-AD0F-F82A6E2B4A21Q29038355-3710CFA9-615D-4CB6-A26C-458AE675E0DBQ30478967-FBF2A637-5543-415C-97A2-16B5AD0F4E6AQ31033315-A64B2162-A495-4A9B-BDD0-CD4DA29A75BAQ34476901-997B1E82-198E-4684-B669-9136086A3F4AQ34544993-78F36616-4691-4859-8B05-5756FEE05769Q34545356-264374DB-0154-4894-A9F5-FB71085B4880Q34565294-54EB82C5-7D84-4098-B744-A8F8E6339E62Q34565712-CF2590B0-CABF-46BA-85ED-B17EAA9E9042Q35105557-24DD2A30-36CB-4243-B272-CEA8DA9364B9Q36020276-8F18A183-A38E-4CBD-A7E8-F408765B7C29Q36629185-6F0DE155-3A28-447E-AAA0-92B6F42E1C64Q36666580-AA82E86C-8C4A-4453-82F9-D7A0639D498EQ36679249-910CEAA0-6405-4BEA-8910-B57DDA2589AAQ36803318-59F9F3B3-A2C8-4009-8F87-BB16E5351A56Q36831009-AE935BA3-E941-4236-AB4D-A4C7CC362459Q36914695-35F5AFD1-B5C1-447C-9237-AA612867B964Q37071511-0D02DFF9-3726-4058-8518-2C4D8D7399A1Q37123827-82FA06B2-E22D-401B-A658-656BA74F98D9Q37166739-AA1F8850-44FC-455D-817C-FB43F21814FAQ37465039-6B694E88-F585-4816-90B1-74BAC7DF826FQ38178521-24BED11D-96A3-47CA-9AA0-AAE276CE72D1Q40164329-32BB052B-50E2-488D-ADE7-506EB245EC9EQ40346595-3F9139A8-84E2-4B87-A1CE-2C6E7897980EQ42517329-254F9E59-A553-4810-97B3-2ED8B2FE782BQ43096892-541BF04E-3C4F-4E4A-8836-28EB64B91E9AQ43743722-2D97A852-47E4-4F60-89C4-6B9E279A221DQ43841260-7A348988-C91D-4073-BA7B-C582CA3B250AQ43956666-A7590E49-5764-4AAE-897B-D6F73D635B38Q44255973-1EC6FFEE-416F-49ED-A42E-62CDC8FE160AQ44359164-25E2B38B-565B-4DF6-80BF-927BDED92DD3Q44787677-5D075503-BB2A-4E06-A616-702936051191Q44880265-5F626BDD-5352-4346-9884-BF80292A8A03Q46726341-4F41EE44-2191-4337-AC92-79332F9EE445Q48169132-EA3A8D11-F912-4692-965F-29A0EADF2705Q48301587-69D5B68B-4155-4DFD-9474-A380B434D50FQ48319552-4E7D01A7-231D-4F83-B941-EA56404588F2Q50588931-0CB6916F-5FE5-4046-A2CB-EB3F4B507637Q52009759-150DC749-8C97-49DD-8ED7-AB149364B426
P2860
Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Long-lasting effects of (+/-)3 ...... nin system function in humans.
@en
Long-lasting effects of (+/-)3 ...... nin system function in humans.
@nl
type
label
Long-lasting effects of (+/-)3 ...... nin system function in humans.
@en
Long-lasting effects of (+/-)3 ...... nin system function in humans.
@nl
prefLabel
Long-lasting effects of (+/-)3 ...... nin system function in humans.
@en
Long-lasting effects of (+/-)3 ...... nin system function in humans.
@nl
P2093
P1476
Long-lasting effects of (+/-)3 ...... nin system function in humans.
@en
P2093
Brambilla F
Delsignore R
Marzocchi GF
Zaimovic A
Zambelli U
P304
P356
10.1016/S0006-3223(99)00180-8
P407
P577
2000-01-01T00:00:00Z